In the competitive field of Digestive Drugs, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Digestive Drugs technology and learn how to protect your intellectual property.

Patent challenges are becoming increasingly common in the Digestive Drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Digestive Drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Digestive Drugs industry

EP3628319Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALS, INC.Nov 14, 2024HOLLATZ, CHRISTIAN
EP3628319Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALS, LTD.Nov 13, 2024STADA-ARZNEIMITTEL AKTIENGESELLSCHAFT
EP3628319Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALS, LTD.Nov 12, 2024TEVA PHARMACEUTICAL INDUSTRIES LTD.
EP3515465Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorREGENERON PHARMACEUTICALS, INC.Nov 7, 2024MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBB
EP3007695Compositions And Methods For Treating AnemiaAKEBIA THERAPEUTICS INC.Nov 6, 2024SANDOZ AG
EP3515465Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorSANOFI BIOTECHNOLOGYNov 6, 2024BOULT WADE TENNANT LLP
EP3515465Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorSANOFI BIOTECHNOLOGYNov 5, 2024BOEHMERT & BOEHMERT ANWALTSPARTNERSCHAFT MBB
EP3628319Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALS, INC.Nov 4, 2024HGF LIMITED
EP3973987Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYOct 10, 2024BOULT WADE TENNANT LLP
EP3973987Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYOct 9, 2024SECERNA LLP

To stay ahead in the competitive Digestive Drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the Digestive Drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP2478907Apr 14, 2021Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGY, INC.22
EP3725778Aug 18, 2021Formulations Of EnzalutamideASTELLAS PHARMA INC.11
EP2637664Mar 29, 2017Compositions And Methods Of Treating Pulmonary HypertensionGILEAD SCIENCES, INC.10
EP2228064Dec 11, 2019Pharmaceutical Composition Containing Glycopyrrolate And A Beta2 Adrenoceptor AgonistNOVARTIS AG10
EP2350096Dec 11, 2019Methods Of Treating Hepatic EncephalopathySALIX PHARMACEUTICALS, LTD.8
EP2400950May 22, 2019Pharmaceutical Formulations Comprising 4-{(1R)-2- [(6-{2-[(2,6-Dichlorobenzyl)Oxy] Ethoxy}Hexyl)Amino]-1-Hydroxyethyl}-2- (Hydroxymethyl)PhenolGLAXO GROUP LIMITED8
EP2981271Nov 14, 2018Therapeutic Uses Of EmpagliflozinBOEHRINGER INGELHEIM INTERNATIONAL GMBH8
EP3703818Nov 1, 2023Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGY7
EP3515465Feb 7, 2024Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorREGENERON PHARMACEUTICALS, INC.7
EP2506850May 13, 2020Methods Of Administering Pirfenidone TherapyINTERMUNE, INC.6